Tracking plasma DNA mutation dynamics in estrogen receptor positive metastatic breast cancer with dPCR-SEQ

npj Breast Cancer

Volumn 4, Issue 1, 2018, Pages

  Kumar, Sunil ^a,b   Lindsay, Daniel ^b   Chen, Q Brent ^a   Garrett, Amy L ^a   Tan, Xianming M ^a,c   Anders, Carey K ^a,b   Carey, Lisa A ^a,b   Gupta, Gaorav P ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHLOROPLAST DNA; CIRCULATING TUMOR DNA; PROTEIN P53;

ALLELE; ARTICLE; BIOINFORMATICS; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; DNA EXTRACTION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEXT GENERATION SEQUENCING; PHLEBOTOMY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SANGER SEQUENCING;

EID: 85068779785     PISSN: None     EISSN: 23744677     Source Type: Journal    
DOI: 10.1038/s41523-018-0093-3     Document Type: Article

References (11)

1. Dawson, S. J. et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Eng. J. Med. 368, 1199–1209 (2013).
2. Fribbens, C. et al. Plasma ESR1 mutations and the treatment of estrogen receptor-positive advanced breast cancer. J. Clin. Oncol. 34, 2961–2968 (2016).
3. Chandarlapaty, S. et al. Prevalence of ESR1 mutations in cell-free DNA and outcomes in metastatic breast cancer: a secondary analysis of the BOLERO-2 Clinical Trial. JAMA Oncol. 2, 1310–1315 (2016).
4. Fribbens, C. et al. Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer. Ann. Oncol. 29, 145–153 (2018).
5. O’Leary, B. et al. Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer. Nat. Commun. 9, 896 (2018).
6. Chu, D. et al. ESR1 mutations in circulating plasma tumor DNA from metastatic breast cancer patients. Clin. Cancer Res. 22, 993–999 (2016).
7. Hrebien, S. et al. Reproducibility of digital PCR assays for circulating tumor DNA analysis in advanced breast cancer. PLoS One 11, e0165023 (2016).
8. Kuderer, N. M. et al. Comparison of 2 commercially available next-generation sequencing platforms in oncology. JAMA Oncol. 3, 996–998 (2017).
9. Kivioja, T. et al. Counting absolute numbers of molecules using unique molecular identifiers. Nat. Methods 9, 72–74 (2011).
10. Chung, J. H. et al. Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer. Ann. Oncol. 28, 2866–2873 (2017).
11. Kumar, S. et al. Supporting metadata for Tracking plasma DNA mutation dynamics in estrogen receptor positivemetastatic breast cancer with dPCR-SEQ. figshare. Collection. https://doi.org/10.6084/m9.figshare.c.4299719 (2018).